Navigation Links
Only 16% of Donations go to New Cancer Treatments in Some Charities. With cureLauncher, 91% of Contributions Go Directly to New Cures for Cancer.
Date:12/5/2012

Bloomfield Hills, MI (PRWEB) December 05, 2012

Vernon Hill is a prostate cancer survivor who led the Relay for Life for three years. He helped raise $900,000, but then suddenly quit. In a story on WNCT News 9, Hill said he believed most of the money went to cancer research. He found out the American Cancer Society puts only 16% of its nearly 1 billion dollar income to what he thinks is most important, cancer research.

According to the American Cancer Society’s Annual Report, 16% of its income goes to “support provided to academic institutions and scientists to seek new knowledge about the causes, prevention and cure of cancer”. Is that a high enough percent to cure cancer?

CureLauncher puts as much money as possible directly into new cancer treatments. “Each person can see exactly where their contribution is used and how it makes a difference”, said President, Stephen Goldner, JD, RAC. "CureLauncher.com lets you see a new breast cancer treatment in development and connect with the dedicated scientists who are saving lives".    

Dr. Lee Roy Morgan is an esteemed cancer research and has been awarded funding by the National Institutes of Health (NIH) for his work. However, government funding cuts to the NIH may prevent Dr. Morgan from advancing his new breast cancer treatment; abbreviated name DM-CHOC-PEN. Contributions on cureLauncher.com will allow Dr. Morgan to continue developing this cure.

“We are working through the FDA to move this program forward as quickly as possible” said Dr. Morgan. Ninety one percent of all money donated on cureLauncher will be used to make drug supplies for the next clinical trial. “These donations will make a huge difference toward our goal of improving cancer patients’ lives”.

Each person who donates $25 or more to Dr. Morgan’s research can write a personal and confidential email and receive Dr. Morgan's reply.

The timing for cureLauncher’s introduction is critical. The fiscal cliff is calling for funding to the NIH to be cut by $2.5 billion and eliminate 300 research grants through the National Cancer Institute, said the Biotechnology Industry Organization.

“Anyone who’s been affected by cancer knows how important it is to find new ways of fighting it”, said cureLauncher Vice President, David Fuehrer. “I am a two-time cancer survivor and alive today because of advances in the way cancer is treated. Now with cureLauncher, even small donations make a big impact”.    

Get involved. Find. Fund. Cure.

About CureLauncher
CureLauncher is an online community dedicated to funding new cancer treatments. It connects patients to lifesaving medical research and generates support for new cancer treatments in a way never before possible. Advocates of the research interact with each other and leading medical professionals to generate support.

Read the full story at http://www.prweb.com/releases/cureLauncher/New_Cancer_Treatment/prweb10205696.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. University of College London Hospitals (UCLH) Selects GEO SCAN Medical as New Standard of Care for the Detection and Treatment of Prostate Cancer
2. Genomic Health Announces Presentation of Six Studies at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium
3. El profesor e investigador mundial líder en cáncer, Paul Workman, se une a The Innovation Debate 2012
4. Prostate Cancer Medical Websites: Friend Or Foe?
5. Cancer Antibodies: Drug Target Atlas and Competitive Outlook
6. On the hunt for rare cancer cells
7. Novel Cancer Immune Therapy Developer Oncos Therapeutics Appoints Experienced Industry Leader Frans Wuite as President and CEO
8. VolitionRxs Preliminary Diagnostic Clinical Trial Results Show High Sensitivity and Specificity for Colon, Breast and Lung Cancers
9. Response Genetics, Inc. to Offer ROS1 Testing for Lung Cancer
10. Lung Cancer Survivors Share Stories of Value of Early Detection and Hope for More Effective Treatments
11. Multimodal Treatment of Peritoneal Metastases Offers Hope for Many Patients With Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
Breaking Biology Technology:
(Date:6/16/2016)... 2016 The global ... reach USD 1.83 billion by 2024, according to ... Technological proliferation and increasing demand in commercial buildings, ... drive the market growth.      (Logo: ... development of advanced multimodal techniques for biometric authentication ...
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
Breaking Biology News(10 mins):